sllrp

Bind Research | Senior Scientist | Full-time | London, UK (ONSITE) | bindresearch.org

We are a UK-based not-for-profit Focused Research Organisation (FRO) committed to improving patient outcomes by turning disordered proteins into viable drug targets.

We are hiring across a number of roles in the areas of machine learning, biomolecular simulation, nuclear magnetic resonance spectroscopy, biochemistry, and protein production.

Find out more and apply here: https://bindresearch.org/careers/

The great advantage of these tracers is that they target actual structures over-expressed in cancers, which means they show far higher specificity than something like FDG. That means they can be used to find micrometastases, and with a different radio-label also be applied for highly targeted radiation therapy.

Source: I used to work in the Heidelberg lab that published this study.